Furthermore, curcumin–chitosan nanoparticles (Cur-CHNPs), either alone or in combination with 5-FU, reduced the expression of OPN and VEGF by dysregulating PI3K and Akt activation, thereby inhibiting breast cancer migration and metastasis [268]. Here, PIK3CA is linked to breast carcinoma.